Public Citizen Challenges Trump's Regulation Executive Order
Executive Summary
A lawsuit claims that President Trump overstepped presidential authority.
You may also be interested in...
US FDA Could Be Mostly Spared From Trump's Regulation-Slashing Order
Even though the executive order that requires regulatory offsets may only have limited application to the agency, industry experts warn that it still could prove to be unwieldly to implement.
Trump's Two-For-One Reg Order Needs Agency Interpretation, Medtech Reg Experts Say
For the most part, industry experts and lobbyists say they still have questions about President Trump's latest executive order, which requires agencies to rescind two regulations for every one rule that is implemented. With key leadership positions at HHS and FDA still unfilled, some say they are taking a wait-and-see approach before concluding how the order will be interpreted.
Top US FDA Drug Policy Leader Leaving For White House Detail
Grail Sipes, CDER deputy center director for regulatory policy, will move to the Executive Office of the President next month.